Related Experiment Videos
[Acyclovir creme in recurrent herpes genitalis]
Summary
Acyclovir cream significantly improved genital herpes outbreaks compared to placebo. Early treatment initiation within four hours of symptom onset yielded the best results for acyclovir efficacy.
Area of Science:
- Dermatology
- Virology
- Pharmacology
Background:
- Genital herpes is a recurrent viral infection.
- Effective treatments are crucial for managing symptoms and improving quality of life.
Purpose of the Study:
- To compare the efficacy of acyclovir (40% cream) versus placebo cream in treating recurrent genital herpes.
- To evaluate the impact of early treatment initiation on therapeutic outcomes.
Main Methods:
- A multicenter, double-blind, placebo-controlled crossover trial.
- Involved 96 patients (65 men, 31 women) with recurrent genital herpes.
- Assessed treatment effectiveness, symptom duration, and side effects.
Main Results:
- Acyclovir cream showed a higher beneficial effect (59.4%) compared to placebo (34.4%).
- Early treatment (within 4 hours) significantly enhanced acyclovir's effectiveness (76.6%).
- Acyclovir reduced pain/burning duration and accelerated lesion healing compared to placebo.
Conclusions:
- Acyclovir 40% cream is an effective treatment for recurrent genital herpes.
- Early intervention with acyclovir cream maximizes therapeutic benefits.
- The treatment demonstrated a favorable safety profile with minimal side effects.